BioStem Technologies, Inc. (BSEM)
3.71
+0.10
(+2.77%)
USD |
NASDAQ |
Sep 04, 16:00
3.78
+0.07
(+1.89%)
After-Hours: 20:00
BioStem Technologies SG&A Expense (TTM) : 44.34M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.34M |
| March 31, 2026 | 79.00M |
| December 31, 2025 | 132.72M |
| September 30, 2025 | 206.49M |
| June 30, 2025 | 269.18M |
| March 31, 2025 | 284.48M |
| December 31, 2024 | 254.75M |
| September 30, 2024 | 167.10M |
| June 30, 2024 | 103.03M |
| March 31, 2024 | 44.70M |
| December 31, 2023 | 13.63M |
| September 30, 2023 | 15.45M |
| June 30, 2023 | 12.38M |
| March 31, 2023 | 9.129M |
| December 31, 2022 | 5.391M |
| September 30, 2022 | 1.93M |
| June 30, 2022 | 0.8494M |
| March 31, 2022 | 0.7128M |
| December 31, 2021 | 0.6581M |
| September 30, 2021 | 0.7663M |
| June 30, 2021 | 0.6735M |
| Date | Value |
|---|---|
| March 31, 2021 | 0.7685M |
| December 31, 2020 | 0.8733M |
| September 30, 2020 | 0.8061M |
| June 30, 2020 | 0.9535M |
| March 31, 2020 | 1.643M |
| June 30, 2019 | 1.780M |
| March 31, 2019 | 1.659M |
| December 31, 2018 | 1.511M |
| September 30, 2018 | 0.8105M |
| June 30, 2018 | 2.106M |
| March 31, 2018 | 2.106M |
| December 31, 2017 | 3.203M |
| September 30, 2017 | 4.214M |
| June 30, 2017 | 4.897M |
| March 31, 2017 | 7.044M |
| December 31, 2016 | 6.381M |
| September 30, 2016 | 5.294M |
| June 30, 2016 | 3.059M |
| March 31, 2016 | 0.7522M |
| June 30, 2014 | 0.1481M |
| March 31, 2014 | 0.0725M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Filana Therapeutics, Inc. | 30.32M |
| CorMedix, Inc. | 138.00M |
| Eloxx Pharmaceuticals, Inc. | 6.133M |
| Cannabis Global, Inc. | 0.0299M |
| Breakthrough Chemistry, Inc. | 0.073M |